Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced the publication of a new retrospective cohort study in Global Spine Journal demonstrating that 3D preoperative planning ...
Investing.com -- Polyrizon Ltd (NASDAQ:PLRZ) stock gained 2.8% on Monday after the pre-clinical-stage biotechnology company announced positive results from an in-vitro study of its PL-14 Allergy ...
Polyrizon Ltd. Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a pre-clinical-stage biotechnology company developing intranasal protective solutions today announced positive results from ...
TipRanks on MSN
Polyrizon announces new pre-clinical results for PL-14
Polyrizon (PLRZ) announced “positive” results from a new in-vitro pre-clinical study evaluating the allergen-blocking performance of its PL-14 ...
Despite randomised clinical trials (RCTs) being the gold standard for drug approval studies, the shift towards precision medicine has increased the use of single-arm trials (SATs). SATs lack results ...
Craig Morgan outlines why comparator clinical trials are useful and provides points to consider to ensure the best outcome. In clinical trials, a comparator drug (defined as ‘an investigational or ...
The clinical trial supply & logistics market grew from USD 26.20 billion in 2024 to USD 28.21 billion in 2025. It is expected to continue growing at a CAGR of 7.96%, reaching USD ...
Toshiba: TC75W71FU, a CMOS dual comparator that features a high-speed response and a full input/output range (Rail to Rail).
Today’s industrial equipment uses large currents in motor drives and power circuits. This brings with it the risk of sudden overcurrent, which can damage equipment, shut down production line, and even ...
In 2023, the World Health Assembly adopted a resolution to strengthen rehabilitation within health systems, calling for ...
This session will explore best practices for sourcing and managing comparator products in clinical trials. It is designed to help sponsors and clinical supply professionals navigate the complexities ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results